FDA Orange Book
Is there a generic for Myqorzo?
Myqorzo contains aficamten. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Myqorzo (aficamten). The Orange Book shows its last listed patent expires July 15, 2042 and its last listed exclusivity ends December 19, 2030.
Run it in Rivvi
Map Myqorzo and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Myqorzo products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 10MG | Marketed (Rx) | None | 0 | None |
| tablet, oral | 15MG | Marketed (Rx) | None | 0 | None |
| tablet, oral | 20MG | Marketed (Rx) | None | 0 | None |
| tablet, oral | 5MG | Marketed (Rx) | None | 0 | None |
NDA 219083, held by CYTOKINETICS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Myqorzo patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 10836755 | January 18, 2039 | Drug substance, Drug product | U-4371 | 219083 |
| 12370179 | July 15, 2042 | Method of use | U-4371 | 219083 |
Myqorzo exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | December 19, 2030 | 219083 |
Myqorzo NDC codes
Questions
Is there a generic for Myqorzo?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Myqorzo (aficamten). The Orange Book shows its last listed patent expires July 15, 2042 and its last listed exclusivity ends December 19, 2030.
What is the generic name for Myqorzo?
The active ingredient in Myqorzo is aficamten, per the FDA Orange Book.
When does the Myqorzo patent expire?
The last patent listed for Myqorzo in the Orange Book expires July 15, 2042. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.